Scot Harper
Directeur Technique/Scientifique/R&D chez RADIOPHARM THERANOSTICS LIMITED
Postes actifs de Scot Harper
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Directeur Technique/Scientifique/R&D | 01/12/2021 | - |
Historique de carrière de Scot Harper
Anciens postes connus de Scot Harper
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENDOCYTE, INC. | Directeur Technique/Scientifique/R&D | 07/05/2013 | 28/10/2016 |
| Corporate Officer/Principal | 07/05/2013 | 14/05/2014 |
Formation de Scot Harper
| University of South Alabama | Graduate Degree |
| DePauw University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Australie | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Entreprise privées | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Bourse
- Insiders
- Scot Harper
- Expérience
